Quotes Newron Pharmaceuticals S.p.A. Deutsche Boerse AG
Stocks
NP5
IT0004147952
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
09:00:50 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 8.710 EUR | +6.22% |
|
-24.33% | -65.93% |
Stock exchange
Deutsche Boerse AG
NP5 9.080 €
+10.73%
3.63K
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| NWRN | 8.210CHF | +0.86% | 475K CHF | ||
Xetra
| NP5 | 8.780EUR | -0.23% | 40.21K € | |
CBOE
| 0QOI | 8.300CHF | +0.73% | 21.49K CHF | |
Tradegate
| NP5 | 8.680EUR | +0.93% | 12.37K € | |
Deutsche Boerse AG
| NP5 | 9.080EUR | +10.73% | 3.63K € | |
Boerse Muenchen
| NP5 | 8.760EUR | +1.86% | 0 € | |
Börse Stuttgart
| NP5 | 8.680EUR | +1.17% | 0 € |
Quotes 5-day view: Newron Pharmaceuticals S.p.A.
Delayed Quote Deutsche Boerse AG| 2026-09-24 | 2026-09-25 | 2026-09-28 | 2026-09-29 | 2026-09-30 | |
|---|---|---|---|---|---|
| Last | €11.60 | €10.50 | €8.200 | €8.200 | €9.080 |
| Volume | 0 | 0 | 8,300 | 0 | 400 |
| Change | -3.33% | -9.48% | -21.90% | 0.00% | +6.22% |
| Opening | €11.60 | €11.40 | €9.900 | €8.200 | €8.400 |
| High | €11.60 | €11.40 | €9.900 | €8.200 | €9.080 |
| Low | €11.60 | €10.50 | €8.200 | €8.200 | €8.400 |
Performance
| 1 day | +6.22% | ||
| 1 week | -24.33% | ||
| Current month | -30.42% | ||
| 1 month | -30.42% | ||
| 3 months | -33.72% | ||
| 6 months | -42.39% | ||
| Current year | -65.93% | ||
| 1 year | -19.79% | ||
| 3 years | +66.61% | ||
| 5 years | +382.47% | ||
| 10 years | +17.30% |
Volumes
marketsDaily volume
400
Estimated daily volume
814
Avg. Volume 20 sessions
590
Daily volume ratio
1.38
Avg. Volume 20 sessions
5,138.9
Avg. Volume 20 sessions USD
5,841.54
Record volume 1
31,741
Record volume 2
27,594
Record volume 3
23,216
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
182,723,493
Market Cap (USD)
207,052,117
Net sales (EUR)
19,126,000
Net sales (USD)
21,672,521
Number of employees
27
Sales / Employee (EUR)
708,370
Sales / Employee (USD)
802,686
Free-Float
87.16%
Free-Float capitalization (EUR)
159,264,503
Free-Float capitalization (USD)
180,469,691
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
10.1
Moving average 20 days
11.84
Moving average 50 days
12.48
Moving average 100 days
13.04
Price spread / (MMA5)
+15.96%
Price spread / (MMA20)
+35.94%
Price spread / (MMA50)
+43.31%
Price spread / (MMA100)
+49.72%
STIM
RSI 9 days
19.46
RSI 14 days
23.99
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.22% | -24.33% | -19.79% | +66.61% | 207M | ||
| -0.70% | -4.28% | +52.62% | +86.42% | 71.53B | ||
| +0.92% | +2.44% | +38.72% | +83.34% | 60.12B | ||
| -0.60% | +3.17% | +9.94% | +37.84% | 48.85B | ||
| -0.73% | -0.41% | +48.84% | +36.72% | 44.28B | ||
| +1.36% | +6.03% | +343.85% | +638.73% | 43.83B | ||
| -0.47% | -0.76% | +9.75% | +103.07% | 41.53B | ||
| +0.34% | +0.22% | +5.18% | +47.36% | 30.13B | ||
| +4.77% | +6.16% | +36.77% | +26.10% | 27.98B | ||
| -1.73% | -4.30% | -18.37% | +357.94% | 25.25B | ||
| Average | +0.92% | -0.06% | +50.75% | +148.41% | 39.37B | |
| Weighted average by Cap. | +0.20% | -0.16% | +63.33% | +147.70% |
Historical Quotes: Newron Pharmaceuticals S.p.A.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
258b2d482e6f.i0btw_WH_GUI_eOAJ-MtTwKsWLLD3-WkG8I-XCFUG0E.5A298r7FtgRpk7T2Rs5HG276IPWWq4LpLJVyK0BtQjvFDr-AuO2uLWm6kA
| Date | Price | Volume | Total |
|---|
Price Extremes
| 1 week | 8.2 | 11.6 | |
| 1 month | 8.2 | 13.15 | |
| Current year | 8.2 | 33.55 | |
| 1 year | 8.2 | 33.55 | |
| 3 years | 4.2 | 33.55 | |
| 5 years | 1 | 33.55 | |
| 10 years | 1 | 33.55 |
Monthly variations
Annual variations
| 2026 | -69.23% | ||
| 2025 | +186.87% | ||
| 2024 | +65.89% | ||
| 2023 | +280.95% | ||
| 2022 | -2.13% | ||
| 2021 | -21.44% | ||
| 2020 | -66.46% | ||
| 2019 | -55.10% | ||
| 2010 | +1.64% | ||
| 2009 | +35.61% | ||
| 2008 | -66.64% | ||
| 2007 | -16.74% | ||
| 2006 | +2.03% |
- Stock Market
- Stocks
- NWRN Stock
- NP5 Stock
- Quotes Newron Pharmaceuticals S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















